RC 251 - Pharmacology II

2 Credits

This course provides an advanced study of pharmacologic agents beyond β₂-agonists and anticholinergics that are essential in the management of asthma, chronic obstructive pulmonary disease (COPD), and related respiratory conditions. Topics include inhaled corticosteroids, phosphodiesterase (PDE) inhibitors, non-steroidal anti-asthmatic agents, mucus-controlling medications, and other adjunct therapies. Emphasis is placed on mechanisms of action, therapeutic applications, and potential adverse effects, preparing students to make evidence-based decisions in clinical practice.

Program Admission Required Yes Admitted Program AAS to BAS - RC
Fees

Quarters Typically Offered
Winter Day

Designed to Serve For students in the Respiratory Care program
Active Date 20260408T15:03:14

Grading Basis Decimal Grade
Class Limit 24
Contact Hours: Lecture 22
Total Contact Hours 22
Degree Distributions:
ProfTech Course Yes
Restricted Elective Yes
Course Outline

Xanthine medications
Inhaled corticosteroids
Non-steroidal anti-asthmatic agents
Mucus-controlling agents

Student Learning Outcomes
Recommend appropriate PDE inhibitor agents for the treatment of airway obstructive diseases.

Recommend appropriate corticosteroid medications for the treatment of pulmonary diseases.

Recommend appropriate non-steroidal agents for the management of asthma and COPD.

Recommend appropriate mucus-controlling agents to aid in secretion clearance and airway management.